REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.50
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.857%)
Open: 17.75
High: 17.75
Low: 17.75
Prev. Close: 17.75
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

Wed, 13th Mar 2024 20:49

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

PensionBee Group PLC - UK online pension provider - Says revenue increased 35% to GBP23.8 million in 2023 from GBP17.7 million a year prior. Pretax loss narrowed to GBP10.7 million from GBP22.4 million. Adjusted loss before interest, tax, depreciation and amortisation shrunk to GBP8.2 million from GBP19.5 million. Basic loss per share dropped 53% to 4.73p from 9.97p. Assets under administration reached GBP4.35 billion at year-end, up 44% from GBP3.03 billion at the end of 2022. Chief Executive Officer Romi Savova says: "Having met our longstanding and ambitious goal of achieving adjusted Ebitda profitability across the fourth quarter of 2023, we are confident in our continued growth, underpinned by profitability...we have announced our proposed expansion into the US, the world's largest defined contribution pension market, where we see an enormous opportunity to assist many consumers in the US who also struggle to prepare adequately for retirement as they navigate a complex and confusing pensions landscape." Looking ahead, PensionBee says it is aiming to onboard 1 million invested customers, creating a revenue ambition of around GBP150 million in the long term.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based drug discovery and development company - Says its pretax loss widened to EUR30.9 million in 2023 from EUR28.7 million a year prior. The company's net assets totalled a negative EUR15.2 million at year-end, increased from a negative EUR11.5 million at the end of 2022. Says trials of its Bexmarilab cancer immunotherapy candidate made significant progress over the year. Chief Executive Officer Markku Jalkanen says: "Throughout the course of the year, we have reported highly encouraging data for bexmarilimab, showing a remarkable overall response rate in both higher-risk frontline MDS patients as well as HMA-failed MDS patients. These are highly significant findings, given the combinations of treatments these patients had previously failed on and the very limited options available for future therapy. They provide us with a path to market and only bolster our confidence in the potential of this novel immunotherapy to treat patients with aggressive hematological malignancies."

----------

Public Policy Holdings Company Inc - Washington DC-based group of advisory firms specialising in government addairs and public relations - Achieves "record financial performance and excellent strategic progress" in 2023. Revenue grew 24% to USD135.0 million from USD108.8 million. Underlying Ebitda rose 12% to USD35.1 million from USD31.2 million, in line with market expectations. Underlying net income increased 14% to USD26.5 million from USD23.3 million. Basic underlying earnings per share rose 9.7% to 23.54 cents from 21.45 cents. PPHC's annual dividend of 14.30 cents per share was 2.1% ahead of 14.00 cents a year before. All business segments achieved year-on-year growth. The company credits its successful year to several acquisitions, including MultiState Associates Inc, which "contribut[ed] healthily to group revenue and Ebitda" over 2023. PPHC continues to target an Ebitda margin of between 25% and 30%, in line with 2023's 26% margin. Chief Executive Officer Stewart Hall says: "The increasing demand for our services has enabled us to generate solid levels of organic growth and healthy expansion in total client numbers. Strategically, we are progressing well with a healthy pipeline of value accretive acquisition opportunities and the strength of our holding company model being validated by the outperformance of our two most recent acquisitions."

----------

Sovereign Metals Ltd - Graphite development company focused on projects in Malawi - In the half-year ended December 31, the company's operating loss was AUD7.0 million, narrowed from AUD8.5 million a year prior. Exploration and evaluation expenditure totalled AUD5.0 million, down from AUD5.8 million, which the company says stems from the pre-feasibility study at its Kasiya project in Malawi. Interest income grew to AUD938,402 from AUD138,366.

----------

Commonwealth Bank of Australia - Sydney-based financial services company and retail bank - Issues subordinated notes worth USD1.25 billion, due March 2034. The notes were issued pursuant to the company's USD50.00 billion senior and subordinated medium term notes program.

----------

OptiBiotix Health Ltd - life sciences company focused on tackling obesity, high cholesterol, diabetes and skincare - Signs partnership agreement with Dr Morepen Ltd, a New Delhi-based diagnostics company, for the sale of SlimBiome weight-loss products in India under the latter's brand. Chief Executive Officer Stephen O'Hara says: "Morepen brings an extensive sales team with experience of highly differentiated scientific products and countrywide access to a network of around 500,000 pharmacies across India. Based on current forecasts, the directors anticipate this agreement could contribute in the region of GBP6-7 million revenue per annum in the next four to five years."

----------

MacFarlane Group PLC - Glasgow-based packaging company - Acquires Allpack Packaging Supplies Ltd, a Bury Saint Edmunds-based packing materials business. Says the "earnings-enhancing acquisition further progresses Macfarlane's strategy to build its protective packaging business through a combination of organic and acquisitive growth". In 2023, Allpack delievered GBP3.0 million in sales alongside Ebitda and pretax profits of GBP600,000. All of Allpack's employees will join MacFarlane. MacFarland will provide a maximum consideration of GBP3.3 million, including a GBP750,000 performance-based earn-out, financed from the company's existing bank facility.

----------

Cora Gold Ltd - gold exploration company focused on Mali and Senegal - Following conversion of USD2.3 million of convertible loan notes for 82.0 million ordinary shares of no par value in the company, has issued an outstanding CLN for a total of USD13.0 million matured on March 12. The company's cash balance is now in excess of USD2.9 million. Chief Executive Officer Bert Monro says: "With strong cash reserves, we look forward to providing progress updates on our Sanankoro gold project in Mali, including submission of the application for a mining permit once the current moratorium is lifted, as well as wider exploration activities across our permits."

----------

Electric Guitar PLC - Reading-based marketing services company - Intends to request the Financial Conduct Authority to cancel the company's shares on the FCA official list and cease admission to trading on the main market of the London Stock Exchange. This is ahead of its proposed application for admission of its shares to trading on AIM. The company expects to convene a shareholder meeting to approve its acquisition of 3radical Ltd in the coming weeks.

----------

Capricorn Energy PLC - Edinburgh-based oil and gas exploration company - Securities and Exchange Board of India has ordered Vedanta Ltd to pay the company USD9.5 million within 45 days. The payment related to a non-payment of a dividend to Capricorn UK Holdings by Vedanta, a Mumbai-based mining company.

----------

Oxford BioDynamics PLC - Oxford-based biotechnology company with a portfolio of clinical tests using its EpiSwitch technology - Announces a fundraising by way of a placing to raise GBP9 million and a retail offer for up to GBP1.3 million, both with an issue price of 9p per share. The issue price represents a 21% discount to the company's closing price of 11.40p on Tuesday. The results of the placing are expects to be released on Thursday. Shares in Oxford BioDynamics closed down 11% at 10.20 pence each in London on Wednesday.

----------

Cooks Coffee Co Ltd - New Zealand-based UK-focused cafe chain - Announces its intention to undertake a placement and share purchase plan. The scheme will result in up to 5.7 million new shares in the company at an issue price of NZD0.20 per share, targeting a raise of up to NZD1.7 million, roughly GBP820,000. Cooks says that the purpose of the fundraise is to invest in improvements in the company's digital programs, including its delivery, click and collect, loyalty programs, as well as expanding its businesses in the Middle East and Europe.

----------

By Hugh Cameron, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
28 Sep 2022 13:57

EARNINGS SUMMARY: Skillcast cuts dividend on swing to interim loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
26 Sep 2022 21:46

TRADING UPDATES: Goldplat appoints chair; 3i portfolios make progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
26 Sep 2022 14:18

OptiBiotix launching new product in deal with Shandong Longlive

(Sharecast News) - Life science company OptiBiotix Health has signed an exclusive distribution agreement with Shandong Longlive Biotechnology, it announced on Monday, for the distribution of Longlive's unique xylooligosaccharide (XOS) prebiotic into the human nutrition markets in Europe and Africa.

Read more
20 Sep 2022 20:50

TRADING UPDATES: Gaming Realms, Northcoders revenue up; Boku wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Sep 2022 11:37

OptiBiotix launches range into large Indian chemist chain

(Sharecast News) - OptiBiotix Health announced on Tuesday that its subsidiary OptiBiotix Ltd launched its 'GoFigure' range with Apollo Hospitals & Pharmacies on 18 September.

Read more
14 Sep 2022 14:25

IN BRIEF: OptiBiotix Health subsidiary signs Asia Pacific agreement

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Says its wholly owned subsidiary OptiBiotix Ltd has signed a services agreement with Nutraconnect Pte Ltd for the Asia Pacific region. Notes that Nutraconnect will develop and implement the go-to-market strategy for prebiotics ingredients SlimBiome and LeanBiome. "Nutraconnect is a nutraceutical business growth acceleration service headquartered in Singapore," the company says.

Read more
24 Aug 2022 15:38

OptiBiotix tumbles as it warns of 'materially lower' sales

(Sharecast News) - Life sciences company OptiBiotix Health said in a trading update on Wednesday that, based on initial figures, it expected first-half sales in its new structure to be "materially lower than expected" at around £0.12m.

Read more
24 Aug 2022 10:43

OptiBiotix shares plunge on "very difficult trading" in half-year

(Alliance News) - OptiBiotix Health PLC on Wednesday lamented a strenuous half-year but eyed growing sales and business, seeing itself in a strong position.

Read more
24 Aug 2022 10:32

AIM WINNERS & LOSERS: Gfinity up on Athlos launch; OptiBiotix slides

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
19 Jul 2022 15:57

UK shareholder meetings calendar - next 7 days

Wednesday 20 July 
ADM Energy PLC AGM
Alkemy Capital Investments PLCAGM
DeepVerge PLCAGM
easyJet PLCGM re purchase of 56 Airbus A320neo family aircraft & conversion of 18 A320neo family aircraft
Fidelity China Special Situations PLCAGM
HarbourVest Global Private Equity LtdAGM
HICL Infrastructure PLCAGM
Novacyt SAAGM 
Plaza Centers NVAGM
Premier Foods PLCAGM
Royal Mail PLCAGM
Triad Group PLCAGM
Wynnstay Properties PLCAGM & GM re share buyback
Thursday 21 July  
Big Yellow Group PLCAGM
Evgen Pharma PLCAGM
Experian PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
Johnson Matthey PLCAGM
Octopus AIM VCT PLCAGM
Pennon Group PLCAGM
Pires Investments PLCGM re offer from Tern PLC
QinetiQ Group PLCAGM
SSE PLCAGM
Tern PLCGM re offer for Pires Investments PLC
Vp PLCAGM
Workspace Group PLCAGM
Zephyr Energy PLCAGM
Friday 22 July  
Chesterfield Resources PLCAGM
Homeserve PLCGM re offer by affiliates of Brookfield Infrastructure Partners LP
JD Sports Fashion PLCAGM
Landore Resources LtdAGM
President Energy PLCAGM
United Utilities Group PLCAGM
WANdisco PLCAGM
Monday 25 July 
BP Marsh & Partners PLCAGM
Keras Resources PLCAGM
Keras Resources PLCGM re share consolidation
Tuesday 26 July 
AO World PLCAGM
Bytes Technology Group PLCAGM
Dekel Agri-Vision PLCAGM
Firering Strategic Minerals PLCAGM
Mitie Group PLCAGM
Momentum Multi-Asset Value Trust PLCAGM
nanosynth group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC & LtdAGM
OnTheMarket PLCAGM
OptiBiotix Health PLCAGM
Telecom Plus PLCAGM
Vodafone Group PLCAGM
Xeros Technology Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Jun 2022 12:19

IN BRIEF: OptiBiotix Health annual profit up; confident in prospects

OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Reports higher profit and revenue in 2021 as probiotic business sells more. Pretax profit rises to GBP6.2 million from GBP5.7 million in 2020. Revenue from contracts with customers grows 45% to GBP2.2 million from GBP1.5 million.

Read more
20 Jun 2022 11:03

OptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-off

(Alliance News) - OptiBiotix Health PLC on Monday noted the change in leadership at its recently AQSE-listed spin-off company ProBiotix Health PLC.

Read more
31 Mar 2022 15:15

IN BRIEF: OptiBiotix spin-off ProBiotix Health starts trading on Aquis

ProBiotix Health PLC - developing probiotics to tackle cardiovascular disease and other lifestyle conditions - Starts trading on Aquis Stock Exchange on Thursday after raising GBP2.5 million in initial public offering. ProBiotix sells 11.9 million shares at 21 pence each, giving the company a GBP25.5 million market capitalisation upon admission. No trades of the stock are reported by AQSE on Thursday. ProBiotix made GBP1.1 million in sales in 2021.

Read more
17 Mar 2022 16:37

OptiBiotix set to list ProBiotix subsidiary on AQSE

(Sharecast News) - OptiBiotix Health announced its intention to list its subsidiary ProBiotix Health on the AQSE Growth Market of the Aquis Stock Exchange on Thursday.

Read more
28 Feb 2022 19:41

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.